';
Physical Disabilities & Aging

The 2026 RCPA Annual Conference Power in Purpose: Promoting Possibilities will be held September 29 – October 2 at the Hershey Lodge for a statewide audience. RCPA’s Conference Committee is seeking workshop proposals in every area for possible inclusion, particularly those that assist providers in developing and maintaining high-quality, stable, and effective treatments, services, and agencies in an industry where change is constant. The committee looks for presentations that:

  • Discuss strategies for C-Suite leadership to advance their organization with adapting to challenges and opportunities;
  • Provide guidance on building a culture of a committed workforce, including recruitment and employee development as well as effective remote workforce strategies;
  • Highlight new policy, research, and treatment initiatives, such as the use of artificial intelligence and technology in service provision;
  • Provide specific skills and information related to individual and organizational leadership development and enhancement;
  • Discuss advanced ethics practices and suicide prevention; and/or
  • Address system changes that affect business practices, including integrated care strategies, value-based purchasing, performance-based contracting, acquisitions and mergers, and alternative payment models.

The committee welcomes any proposal that addresses these and other topics essential to rehabilitation, mental health, substance use disorder, children’s health, aging, physical disabilities, intellectual/developmental disabilities, and autism. Members are encouraged to consider submitting, and we highly encourage you to forward this opportunity to those who are exceptionally good speakers and have state-of-the-art information to share.

The Call for Proposals (featuring a complete listing of focus tracks) and accompanying Guidelines for Developing Educational Objectives detail requirements for submissions. The deadline for submissions is COB Monday, March 23, 2026. Proposals must be submitted electronically with the form provided; confirmation of receipt will be sent. Proposals submitted after the deadline may not be considered.

If the proposal is accepted, individuals must be prepared to present on any day of the conference. Workshops are 90 minutes in length. If the topic requires an in-depth presentation, a double session can be scheduled for a total of 180 minutes. At the time of acceptance, presenters will be asked to confirm the ability to submit workshop slides and handouts electronically two weeks prior to the conference. Individuals unable to meet this expectation may not have their materials available to participants during the conference.

Individuals are welcome to submit more than one proposal; however, we ask that you submit no more than three total. Notification of inclusion for the conference will be made via email by Monday, May 11, 2026. Questions may be directed to Carol Ferenz, Conference Coordinator.

The Long-Term Services and Supports (LTSS) Subcommittee meeting was held on January 7, 2026. During the meeting, a number of presentations were given.

Members should take time to review the agenda and PowerPoint presentations from the meeting below:

The next LTSS Subcommittee meeting is scheduled for February 4, 2026 (virtual only) from 10:00 am – 1:00 pm. To participate, register for the meeting here. The call information is below:

Thursday, February 5, 2026
1:00 pm – 2:00 pm EST; 12:00 pm – 1:00 pm CST;
11:00 am – 12:00 pm MST; 10:00 am – 11:00 am PST
Register Here

This webinar is a follow-up to Dr. Bohl’s January 2025 webinar Understanding and Treating Pediatric Vision Impairments, including additional practical treatment options. Attendees may wish to review the former presentation prior to attending.

Presenter Bio:

Dr. Bohl earned her Doctor of Optometry degree from the University of the Incarnate Word Rosenberg School of Optometry in San Antonio, Texas, and completed a residency in neuro-optometric rehabilitation through the State University of New York College of Optometry. Dr. Bohl joined the team at Madonna Rehabilitation Hospital in 2017, where she supports individuals with vision impairments in the rehabilitation setting.

Objectives: At the end of this session, the learner will:

  • Review therapy techniques beneficial to pediatric patients with visual deficits;
  • Identify when to use techniques to benefit peripheral awareness, pursuits, saccades, visual perceptual skills, and functional binocularity; and
  • Adapt therapeutic interventions to adjust levels of difficulty and ensure appropriateness for different age populations.

Audience: This webinar is intended for all interested members of the rehabilitation team.

Level: Beginner – Intermediate

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are provided for this course.

Complimentary webinars are a benefit of IPRC/RCPA membership. Registration fee for non-members is $179. Not a member yet? Consider joining today.

Congressman Brett Guthrie, Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith, Chairman of the Subcommittee on Health, recently announced a hearing “Legislative Proposals to Support Patient Access to Medicare Services.”

This Subcommittee on Health hearing will be held on January 8, 2026, at 10:15 am to discuss legislation focused on improving Medicare payment policies and expanding access to care for seniors.

The hearing will focus on the following bills:

  • H.R. 1703, Choices for Increased Mobility Act of 2025 (Rep. Joyce – PA)
  • H.R. 2005, DMEPOS Relief Act of 2025 (Rep. Miller-Meeks)
  • H.R. 2172, Preserving Patient Access to Home Infusion Act (Rep. Buchanan)
  • H.R. 2477, Portable Ultrasound Reimbursement Equity Act of 2025 (Rep. Van Duyne)
  • H.R. 2902, Supplemental Oxygen Access Reform (SOAR) Act of 2025 (Rep. Valadao)
  • H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. (Rep. McClellan)
  • H.R. 5269, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 (Rep. Hudson)
  • H.R. 5347, Health Care Efficiency Through Flexibility Act (Rep. Buchanan)
  • H.R. 6210, Senior Savings Protection Act (Rep. Matsui)
  • H.R. 6361, Ban AI Denials in Medicare Act (Rep. Landsman)

The hearing will be open to the public as well as livestreamed. Questions about the hearing should be directed to Annabelle Huffman.

Tuesday, January 6, 2026
1:00 pm – 2:00 pm ET; 12:00 pm – 1:00 pm CT;
11:00 am – 12:00 pm MT; 10:00 am – 11:00 am PT
Register Here

Please join us as the IPRC hosts special guest Terry Carolan from CARF International, who will share the new Disorders of Consciousness Program Standards.

Presenter Bio:

Terrence Carolan
Terrence Carolan, Managing Director of the Medical Rehabilitation and Aging Services accreditation areas at the Commission on Accreditation of Rehabilitation Facilities (CARF), has more than 20 years of experience as a provider, administrator, and educator in the human services field. Terry joined CARF after working in clinical and administrative leadership positions within Select Medical’s Inpatient Rehabilitation Division and the Kessler Institute for Rehabilitation since 2001. Terry was a CARF surveyor for 10 years and holds a degree in physical therapy from Simmons College in Boston. He also recently completed his master’s degree in business administration from the University of Wisconsin-Eau Claire.

Objectives: At the end of this session, the learner will:

  • Describe recent research and guidance on the treatment of individuals with Disorders of Consciousness (DoC);
  • Discuss how CARF International has responded to guidance from the field to create Disorders of Consciousness Program Standards; and
  • Analyze how new DoC accreditation and recent research will enhance access to rehabilitation for children with DoC in the future.

Audience: This webinar is intended for all interested members of the rehabilitation team; attendees do not need to be CARF certified in order to attend.

Level: Beginner-Intermediate

Certificate of Attendance: Certificates of attendance are available for all attendees. No CEs are available for this course.

Following the creation of the Rural Health Transformation (RHT) Program under President Trump’s Working Families Tax Cut legislation, the Centers for Medicare and Medicaid Services (CMS) has announced the establishment of the Office of Rural Health Transformation (ORHT). This new office will be located within the Center for Medicaid and CHIP Services (CMCS) and will continue overseeing the RHT Program. The RHT Program is a $50 billion initiative to strengthen rural health systems and expand access to care nationwide. As noted in RCPA’s Alert from December 30, 2025, Pennsylvania will receive nearly $200 million in 2026.

ORHT, which announced approved awardees on December 29, 2025, will guide states in implementing their rural health transformation plans, provide technical assistance, coordinate federal and state partnerships, and ensure strong oversight and accountability throughout the five-year program, which will run through September 30, 2031.

Businesswoman using smartphone with monthly calendar to plan 2025 activities. Scheduling and organizing plans. Technology and business concept.

Due to scheduling conflicts, the March 2026 date for the Long-Terms Services and Supports Subcommittee (LTSS) meeting has been changed. The meeting has been changed from March 4, 2026, to March 11, 2026. The meeting will be held via webinar and remote streaming, from 10:00 am – 1:00 pm.

Questions and comments may be submitted electronically.

Dexcom Issues Correction for Dexcom G6 and G6 Pro Software:

This recall involves correcting devices and does not involve removing the devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction.

Affected Product

  • Product Name: Dexcom G6 Continuous Glucose Monitoring System G6 and G6 Pro Android US CGM App, Version 1.15.0
  • This correction only affects users of v.1.15.0 of the Android US App and does not apply to other users. All affected devices have been updated to resolve this issue.
  • Unique Device Identifier (UDI): SW11678: 00386270000811

What to Do
Upgrade from app version 1.15.0 as soon as possible.

On September 18, Dexcom Inc. sent all affected customers an Urgent Medical Device Correction message recommending the following actions:

  • Upgrade from app version 1.15.0 as soon as possible.
    • Open App Store and search for Dexcom G6 app.
    • Install latest Dexcom G6 app version.
    • Open Dexcom G6 app.
  • Contact Technical Support at 1-844-478-1600 for further assistance.
  • Users will no longer be able to use app version 1.15.0 after October 6, 2025.

Reason for Correction
Dexcom Inc. is correcting the Dexcom G6 Continuous Glucose Monitoring System’s G6 and G6 Pro Android US CGM App version 1.15.0 due to an identified bug that can cause the app to terminate unexpectedly. As a result, the user may not receive estimated glucose values, alarms, or alerts. If a user is unaware that the app has terminated, there is potential for missed detection of a high blood sugar (hyperglycemic) or low blood sugar (hypoglycemic) event.

The use of affected product may cause serious adverse health consequences, including hyperglycemia, hypoglycemia, and death.

As of September 16, Dexcom has not reported any serious injuries or deaths associated with this issue.

Device Use
The Dexcom G6 Continuous Glucose Monitoring System is a real-time continuous glucose monitoring system that sends glucose readings to a compatible smart device or the Dexcom receiver every five minutes. The Dexcom G6 and G6 Pro Android US CGM App is an application for compatible smart devices that displays glucose levels and trends.

Contact Information
Customers in the U.S. with questions about this recall should contact Dexcom Technical Support at 1-844-478-1600.

Additional FDA Resources

Unique Device Identifier (UDI)
The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.